Rocking the foundations of solid tumor growth by attacking the tumor's blood supply
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 19 (9) , 392-394
- https://doi.org/10.1016/s0167-5699(98)01314-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Designing Therapies That Target Tumor Blood VesselsScience, 1997
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal Of Cancer, 1996
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Vascular endothelial growth factor B, a novel growth factor for endothelial cells.Proceedings of the National Academy of Sciences, 1996
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993